Tremfya

Product manufactured by Janssen Biotech, Inc.

Application Nr Approved Date Route Status External Links
BLA761061 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Tremfya Is An Interleukin-23 Blocker Indicated For The Treatment Of Adult Patients With: Moderate-To-Severe Plaque Psoriasis Who Are Candidates For Systemic Therapy Or Phototherapy ( 1.1 ) Active Psoriatic Arthritis. ( 1.2 ) 1.1 Plaque Psoriasis Tremfya ® Is Indicated For The Treatment Of Adults With Moderate-To-Severe Plaque Psoriasis Who Are Candidates For Systemic Therapy Or Phototherapy. 1.2 Psoriatic Arthritis Tremfya Is Indicated For The Treatment Of Adult Patients With Active Psoriatic Arthritis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Guselkumab

Comments